News
02/03/2012
The Government Accountability Office (GAO) issued a report looking at the pricing and transparency of costs for certain medical devices, focusing on implantables such as stents and artificial knees...
02/01/2012
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the tentative agreement between FDA and industry...
01/27/2012
MDMA recently submitted comments with the Centers for Medicare & Medicaid Services (CMS) about their efforts on Coverage with Evidence Development (CED). "MDMA supports CMS's efforts to...
01/24/2012
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement regarding President Obama’s State of the Union Address:
“...
01/18/2012
A new report by the National Science Board, the policymaking body for the National Science Foundation (NSF) detailed the strengths and weaknesses of America's R&D sector while noting the...
01/12/2012
In one of the first decisions for what is expected to be a uniquely challenging year for reimbursement policies, the Medicare Payment Advisory Commission (MedPAC) recommended that Medicare...
01/06/2012
On Thursday, January 19th, at 2pm ET/11am PT, MDMA will host an important Member-Only webinar to discuss the priorities for the year ahead. This webinar will focus on the 2012 Public...
01/02/2012
FDA issued numerous draft guidances over the past two weeks addressing various aspects of its proposed action plan. They included:
510(k) Paradigm Draft Guidance
Product Code Draft Guidance
Draft...
12/14/2011
WASHINGTON – MDMA President and CEO Mark Leahey issued the following statement in response to the Centers for Medicare and Medicaid Services’ (CMS) proposed rule on physician payment disclosure:“We...
12/07/2011
Senators Scott Brown (MA) and Kelly Ayotte (NH) introduced legislation this week to improve the de novo process for medical technology innovators, and to increase predictability in the regulatory...
